Yes, You Should Call the Patient
An INR of 1.1 in a patient on warfarin is significantly subtherapeutic and requires immediate intervention to prevent thromboembolism. This patient is essentially unprotected from clot formation and needs prompt dose adjustment and follow-up INR testing.
Why This Matters
The therapeutic INR range for most indications (atrial fibrillation, venous thromboembolism, mechanical heart valves) is 2.0-3.0 1. An INR of 1.1 means the patient has minimal anticoagulation effect—they are at substantial risk for the very complications warfarin is meant to prevent.
Research demonstrates that subtherapeutic INR values significantly increase thrombotic risk. In stroke patients on warfarin, those with low INR values had substantially higher rates of ischemic events, with mean INR of 1.7 in ischemic patients versus 2.8 in those without ischemia 2. Your patient at 1.1 is even further below therapeutic range.
Immediate Actions Required
Contact the patient today to:
- Assess compliance: Determine if doses were missed, if the patient switched to generic warfarin (which can cause INR fluctuations 3), or if new medications were started
- Review potential drug interactions: Many medications can lower INR 1
- Adjust the warfarin dose: Increase the maintenance dose based on how far below target the INR is
- Schedule repeat INR testing: Recheck INR within 3-5 days after dose adjustment to ensure therapeutic range is achieved 4
The Evidence Behind Urgent Intervention
The ACCP guidelines specifically address subtherapeutic INRs. While they suggest that single out-of-range INRs within 0.5 of therapeutic (e.g., INR 1.5-1.7 when target is 2.0-3.0) may not require dose changes 4, an INR of 1.1 is far below this threshold and represents inadequate anticoagulation.
The FDA labeling emphasizes that warfarin dosing must be individualized based on INR response, with regular monitoring essential to prevent both thrombosis and bleeding 1. An INR of 1.1 indicates the current regimen is failing.
Common Pitfalls to Avoid
- Don't wait for the next scheduled INR: This patient needs intervention now, not at their routine follow-up
- Don't assume this is just normal variation: An INR this low suggests a systematic problem (missed doses, drug interaction, dietary changes, or inadequate dosing)
- Don't make small dose adjustments: An INR of 1.1 typically requires a meaningful dose increase, not just 5-10% adjustments
- Don't forget bridging consideration: Depending on the indication (particularly mechanical heart valves or recent VTE), consider whether bridging with low molecular weight heparin is needed while re-establishing therapeutic INR 4
Risk Stratification by Indication
The urgency varies by why the patient is anticoagulated:
- Mechanical heart valves: Highest risk—consider bridging therapy while adjusting warfarin 1
- Atrial fibrillation with high stroke risk: Very concerning—rapid dose adjustment needed 1
- Recent VTE (within 3 months): High risk of recurrent thrombosis 2, 5
- Remote VTE or lower-risk AF: Still requires intervention but slightly less urgent
Research shows that smoking increases VTE recurrence risk 5, and patients with active cancer have higher bleeding risk when anticoagulation is intensified 5—factors to consider in your management plan.
Bottom line: An INR of 1.1 is a red flag requiring same-day contact, dose adjustment, and close follow-up INR monitoring within 3-5 days.